These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 32715960)

  • 41. Pharmacy practice in emergency response during the COVID-19 pandemic: Lessons from Australia.
    Parajuli DR; Khanal S; Wechkunanukul KH; Ghimire S; Poudel A
    Res Social Adm Pharm; 2022 Aug; 18(8):3453-3462. PubMed ID: 34810136
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The Role of Compounding Pharmacists During Drug Shortages.
    Ofei K
    Int J Pharm Compd; 2022; 26(4):298-301. PubMed ID: 35820135
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Strategy of pharmaceutical care services for clinical Chinese pharmacists in coronavirus disease 2019 (COVID-19)].
    Lin ZJ; Zhang B
    Zhongguo Zhong Yao Za Zhi; 2020 Mar; 45(6):1259-1262. PubMed ID: 32281334
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Controls to Minimize Disruption of the Pharmaceutical Supply Chain During the COVID-19 Pandemic.
    Cundell T; Guilfoyle D; Kreil TR; Sawant A
    PDA J Pharm Sci Technol; 2020; 74(4):468-494. PubMed ID: 32467176
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hospital pharmacist challenges in evaluation of scientific evidence and its incorporation to pharmacotherapeutic protocols through therapeutic committees in COVID-19 times.
    Fernández-Llamazares CM; López-Briz E
    Farm Hosp; 2020 Jun; 44(7):24-27. PubMed ID: 32533665
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The Role of Pharmacists in the Fight Against COVID-19.
    Chahine EB
    Sr Care Pharm; 2020 Jul; 35(7):286-291. PubMed ID: 32600505
    [TBL] [Abstract][Full Text] [Related]  

  • 47. COVID-19 emergency responders in FDA's Center for Drug Evaluation and Research.
    Gormley LCA; Ngan CK
    J Am Pharm Assoc (2003); 2020; 60(3):527-528. PubMed ID: 32336674
    [No Abstract]   [Full Text] [Related]  

  • 48. The pharmacist facing the logistics of safely dispensing, storing and preserving drugs in healthcare units.
    Cabañas MJ; Queralt Gorgas M
    Farm Hosp; 2020 Jun; 44(7):53-56. PubMed ID: 32533672
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical research in hospital pharmacy during the fight against COVID-19.
    Castro-Balado A; Varela-Rey I; Bandín-Vilar EJ; Busto-Iglesias M; García-Quintanilla L; Mondelo-García C; Fernández-Ferreiro A
    Farm Hosp; 2020 Jun; 44(7):66-70. PubMed ID: 32533675
    [TBL] [Abstract][Full Text] [Related]  

  • 50. COVID-19 pandemic planning, response, and lessons learned at a community hospital.
    Schiller DS; Fulman M; Champagne J; Awad N
    Am J Health Syst Pharm; 2020 Aug; 77(17):1371-1374. PubMed ID: 32417882
    [No Abstract]   [Full Text] [Related]  

  • 51. Cancer, immune suppression and Coronavirus Disease-19 (COVID-19): Need to manage drug safety (French Society for Oncology Pharmacy [SFPO] guidelines).
    Slimano F; Baudouin A; Zerbit J; Toulemonde-Deldicque A; Thomas-Schoemann A; Chevrier R; Daouphars M; Madelaine I; Pourroy B; Tournamille JF; Astier A; Ranchon F; Cazin JL; Bardin C; Rioufol C
    Cancer Treat Rev; 2020 Aug; 88():102063. PubMed ID: 32623296
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The role of a Coronavirus disease 2019 pharmacist: an Australian perspective.
    Nguy J; Hitchen SA; Hort AL; Huynh C; Rawlins MDM
    Int J Clin Pharm; 2020 Oct; 42(5):1379-1384. PubMed ID: 32472325
    [TBL] [Abstract][Full Text] [Related]  

  • 53. ICU pharmacist describes challenges in COVID-19 care.
    Traynor K
    Am J Health Syst Pharm; 2020 Jul; 77(15):1183-1184. PubMed ID: 32620973
    [No Abstract]   [Full Text] [Related]  

  • 54. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Perseverance in a pandemic: A unique pharmacy residency learning experience.
    Campbell P; Witenko C; Dzierba AL
    Am J Health Syst Pharm; 2020 Sep; 77(18):1459-1460. PubMed ID: 32497194
    [No Abstract]   [Full Text] [Related]  

  • 56. Drugs supply and pharmaceutical care management practices at a designated hospital during the COVID-19 epidemic.
    Ying W; Qian Y; Kun Z
    Res Social Adm Pharm; 2021 Jan; 17(1):1978-1983. PubMed ID: 32317153
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hospital Pharmacy Compounding against COVID-19 pandemic.
    Alonso-Herreros JM; Berisa-Prado S; Cañete-Ramírez C; Dávila-Pousa C; Flox-Benítez MDP; Ladrón de Guevara-García M; López-Cabezas C; Martín de Rosales-Cabrera AM; Ramos-Martínez B
    Farm Hosp; 2020 Jun; 44(7):49-52. PubMed ID: 32533671
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Proposed model for hospital and community pharmacy services during COVID-19 pandemic in Nigeria.
    David KB; Adebisi YA
    Int J Pharm Pract; 2020 Oct; 28(5):544-545. PubMed ID: 32621648
    [No Abstract]   [Full Text] [Related]  

  • 59. Drug Shortages Prior to and During the COVID-19 Pandemic.
    Callaway Kim K; Rothenberger SD; Tadrous M; Hernandez I; Gellad WF; Devine JW; Hershey TB; Maillart LM; Suda KJ
    JAMA Netw Open; 2024 Apr; 7(4):e244246. PubMed ID: 38578641
    [TBL] [Abstract][Full Text] [Related]  

  • 60. American Society for Transplantation and Cellular Therapy Pharmacy Special Interest Group Position Statement on Pharmacy Practice Management and Clinical Management for COVID-19 in Hematopoietic Cell Transplantation and Cellular Therapy Patients in the United States.
    Mahmoudjafari Z; Alexander M; Roddy J; Shaw R; Shigle TL; Timlin C; Culos K
    Biol Blood Marrow Transplant; 2020 Jun; 26(6):1043-1049. PubMed ID: 32305359
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.